← Back to front page
Oceania · General news · The Australian

Recce inks Australia and NZ licensing deal for diabetic foot infections gel

Published by The Australian · Australia 9 h ago

Recce Pharmaceuticals has signed an exclusive licensing and commercialisation agreement with Arrotex Pharmaceuticals for its RECCE 327 (R327G) topical gel to treat diabetic foot…

Read the full article on The Australian Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theaustralian.com.au)

Also worth reading

The Age

Marnus throws away wicket with brain snap

 Brisbane Times

Marnus throws away wicket with brain snap

 WAtoday

Marnus throws away wicket with brain snap

 PerthNow

Helen Haines’ Save the Children campaign raises $350k in less than 24 hours

 iTWire

ECI Software Solutions Names Ron Books Chief Executive Officer

 The Canberra Times

Man 'covered in blood' after supermarket glassing reported in Canberra's south